fulvestrant (Faslodex)

Introduction

Tradename: Faslodex

Indications

• metastatic breast cancer
• postmenopausal women with cancer progression on tamoxifen

Dosage

monthly IM injections

Adverse effects

• injection site reaction
• similar to other estrogen receptor antagonists
  • hot flashes
  • nausea

Mechanism of action

• estrogen receptor antagonist

Notes

Manufacturer: AstraZeneca

More general terms

• antineoplastic endocrine agent
• estrogen antagonist

Database

• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=104741
• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5284640